<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="2-part\PMC6780377\results\search\tropicalVirus\results.xml">
  <result pre="Contemporary Strategies and Current Trends in Designing Antiviral Drugs against" exact="Dengue" post="Fever via Targeting Host-Based Approaches https://orcid.org/0000-0001-7313-4729AhammadFoysal1Tengku Abd RashidTengku Rogayah2https://orcid.org/0000-0001-7783-8950MohamedMaizan3TanbinSuriyea1Ahmad"/>
  <result pre="of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract" exact="Dengue" post="virus (DENV) is an arboviral human pathogen transmitted through"/>
  <result pre="that can prevent or treat infections resulting from this pathogen." exact="DENV" post="utilizes numerous host molecules and factors for transcribing the"/>
  <result pre="utilized by the pathogens, targeting these factors may result in" exact="DENV" post="inhibitors, and will play an important role in attenuating"/>
  <result pre="the progress made in the development of host-based approaches for" exact="DENV" post="viral infections, focusing on host cellular mechanisms and factors"/>
  <result pre="host-dependent antiviral therapeutics. dengue virus (DENV) antiviral drugs drug targets" exact="DENV" post="host factors host metabolism DENV inhibitors arthropod-borne viruses 1."/>
  <result pre="(DENV) antiviral drugs drug targets DENV host factors host metabolism" exact="DENV" post="inhibitors arthropod-borne viruses 1. Introduction Dengue is an important"/>
  <result pre="host factors host metabolism DENV inhibitors arthropod-borne viruses 1. Introduction" exact="Dengue" post="is an important arthropod-borne viral infectious disease caused by"/>
  <result pre="viral serotypes. The antigenically distinct but closely related serotypes of" exact="DENV" post="belong to the genus Flavivirus, family Flaviviridae. Its rapid"/>
  <result pre="more than 70 small-enveloped viruses related to Japanese encephalitis (JEV)," exact="Zika" post="viruses (ZIKV), West Nile (WNV), yellow fever virus (YFV),"/>
  <result pre="small-enveloped viruses related to Japanese encephalitis (JEV), Zika viruses (ZIKV)," exact="West Nile" post="(WNV), yellow fever virus (YFV), DENV, or tick-borne encephalitis"/>
  <result pre="tick-borne encephalitis (TBEV), and other medically-important arboviruses [3]. Most importantly," exact="DENV" post="is endemic in 112 countries, and incidence of infection"/>
  <result pre="is estimated that ~400 million individuals suffer annually because of" exact="DENV" post="infection [5]. DENV infection results in varying degrees of"/>
  <result pre="~400 million individuals suffer annually because of DENV infection [5]." exact="DENV" post="infection results in varying degrees of clinical signs and"/>
  <result pre="(DSS) [6]. However, specific therapeutics are presently not available for" exact="DENV" post="infections [7], necessitating an improved approach for re-mediating this"/>
  <result pre="we will explore the host factors or targets that influence" exact="DENV" post="replication, focusing on the factors that can potentially be"/>
  <result pre="believed that it was not only dengue, but that the" exact="Chikungunya" post="virus was also responsible for the epidemics [10,11]. The"/>
  <result pre="(1919) and Siler et al. (1926) subsequently confirmed that the" exact="DENV" post="transmission process was akin to the &quot;jungle cycle�? of"/>
  <result pre="(Japan) and Dr. S. Hotta (Hawaii) isolated and identified the" exact="DENV" post="strains DENV-1 and DENV-2 [19]. In 1953, the DENV-3"/>
  <result pre="Philippines and Thailand [20]. 1.2. Vector and Non-Vector Transmission of" exact="Dengue" post="In most cases, DENV transmission is accomplished by the"/>
  <result pre="1.2. Vector and Non-Vector Transmission of Dengue In most cases," exact="DENV" post="transmission is accomplished by the primary vectors, whereby A."/>
  <result pre="[6]. Other species that act as secondary vectors for carrying" exact="DENV" post="include Aedes scutellaris, Aedes africanus (subgenus Stegomyia) and Aedes"/>
  <result pre="dengue vectors for carrying dengue infectious virus [22,23]. The non-mosquito" exact="DENV" post="transmission route is infrequent and accidental, but it has"/>
  <result pre="congenitally, through mucocutaneous exposure, and through bone marrow transplants [24]." exact="DENV" post="infection of healthcare workers usually occurs as a result"/>
  <result pre="locations in tropical Africa and Asia, probable rates of sylvatic" exact="DENV" post="transmission to humans are unknown, but appeared to be"/>
  <result pre="of new-world non-human primates were found to be resistant to" exact="DENV" post="infection, and no cases of sylvatic DENV transmission were"/>
  <result pre="be resistant to DENV infection, and no cases of sylvatic" exact="DENV" post="transmission were recorded. Similarly, no evidence of enzootic circulation"/>
  <result pre="of Bolivia, where A. aegypti is absent, recommend that sylvatic" exact="DENV" post="transmission may happen in the region [44]. Cross-species transmission"/>
  <result pre="transmission may happen in the region [44]. Cross-species transmission of" exact="DENV" post="in rural areas of Africa and Asia from non-human"/>
  <result pre="[47,48]. DENV-infected small A. aegypti bite humans and thus initiate" exact="DENV" post="transmission. These mosquitos lay eggs and rest indoors in"/>
  <result pre="feed on several persons, thus rapidly accelerating the transmission of" exact="DENV" post="[49]. After transmission into the human host and following"/>
  <result pre="2. Targeting Host as an Antiviral Approach The significance of" exact="DENV" post="and its mechanism of interaction with host factors must"/>
  <result pre="host factors must be fully understood for proper morphogenesis of" exact="DENV" post="for targeting host processes as an antiviral therapy. The"/>
  <result pre="protein kinase IIb (CAM K2B) [55,56]. On the other hand," exact="West Nile" post="virus (WNV) replication is associated with intracellular membrane rearrangements,"/>
  <result pre="pathways, as well as membrane re-modelling of the host [57,58]." exact="DENV" post="is not exceptional from the other viruses—it also depends"/>
  <result pre="machinery to complete its life cycle. In order to understand" exact="DENV" post="host dependent factors, a genome-wide screen to explain DENV"/>
  <result pre="understand DENV host dependent factors, a genome-wide screen to explain" exact="DENV" post="host dependency for their life cycle in Drosophila melanogaster"/>
  <result pre="has been published [59]. Later, different conservative genome-wide screens of" exact="DENV" post="identified different host-dependent factors responsible for their replication, where"/>
  <result pre="factors, and anti-inflammatory pathways are most commonly found to influence" exact="DENV" post="replication and infection. Different host and viral factors play"/>
  <result pre="an immunopathogenic response. From the hypothesis, we can understand that" exact="DENV" post="serotypes are propagated in endemic areas, and pre-existing immunity"/>
  <result pre="severe dengue cases in the frame of all the four" exact="DENV" post="serotypes. Prior to evaluation, sometimes targeting the factors is"/>
  <result pre="Targeting intracellular metabolic pathways and their pharmacological inhibition can reduce" exact="DENV" post="RNA synthesis and infectious virion production [60], which may"/>
  <result pre="and infectious virion production [60], which may serve as successful" exact="DENV" post="antiviral strategies. For example, lipid and glucose metabolic pathways"/>
  <result pre="cycle of DENV. Both steps in the replication cycles of" exact="DENV" post="can be inhibited by different pharmacological agents, and the"/>
  <result pre="mechanisms by which specific glucose and lipids are generated during" exact="DENV" post="infection, as well as its trafficking to the relevant"/>
  <result pre="blocks, and other important molecules required for viral replication. In" exact="DENV" post="infection, a major change occurs in the central carbon"/>
  <result pre="is up-regulated and glucose consumption is increased in DENV-infected cells." exact="DENV" post="activates the glycolytic pathway for viral metabolic requirements and"/>
  <result pre="case cancer cells and human cytomegalovirus (HCMV) cells [3,4,5,6]. As" exact="DENV" post="activates the host glycolytic pathway for generating their necessary"/>
  <result pre="necessary building blocks, pharmacologic regulation of glycolysis significantly blocks infectious" exact="DENV" post="production. Krystal and colleagues reported that glycolysis inhibition through"/>
  <result pre="d-glucose (2DG) treatment can result in a significant reduction in" exact="DENV" post="replication [5]. 3.2. Targeting the Host Lipid Biosynthesis Pathway"/>
  <result pre="Targeting the Host Lipid Biosynthesis Pathway As an enveloped virus," exact="DENV" post="stimulates the lipid biosynthesis pathway for essential membrane formation."/>
  <result pre="A (AcCoA) for generating most distinct membrane lipids (Figure 2)." exact="DENV" post="stimulates fatty acid biosynthesis by the help of the"/>
  <result pre="autophagy that transports lipids for β-oxidation. Several studies indicate that" exact="DENV" post="infection induces pro-viral autophagy [62,63,64,65,66]. The lipids accumulated in"/>
  <result pre="energy and plays a key role in lipophagy, thus assisting" exact="DENV" post="replication. Additionally, NADPH that arises through β-oxidation utilizes a"/>
  <result pre="FASN and it may stimulate the fatty acid synthesis for" exact="DENV" post="replication. In DENV-infected cells, both fatty acid synthesis and"/>
  <result pre="decarboxylase, an enzyme required for cholesterol biosynthesis [60], can decrease" exact="DENV" post="production in host cells. 3.3. Targeting the Host Nucleoside"/>
  <result pre="DHODH inhibitor), an anti-metabolite in cancer and immune-suppression, can inhibit" exact="DENV" post="type 1,2,3 (DENV-1,2,3) serotypes. However, it cannot inhibit DENV"/>
  <result pre="inhibit DENV type 1,2,3 (DENV-1,2,3) serotypes. However, it cannot inhibit" exact="DENV" post="type 2 (DENV-2) variants because of resistance against brequinar,"/>
  <result pre="vitro study of the compound shows a great potency against" exact="DENV" post="serotypes, but the compound did not show any efficacy"/>
  <result pre="Targeting the enzymes that play a key role in supplying" exact="DENV" post="nucleoside can therefore be effective for antiviral therapeutics. 4."/>
  <result pre="at the cellular level play a key role in the" exact="DENV" post="virus entry process, but attachment factors and receptors are"/>
  <result pre="reported as potential treatment candidates. Targeting host factors involved in" exact="DENV" post="attachment can thus have a beneficial antiviral potential. 4.1."/>
  <result pre="the family of glycosaminoglycans (GAGs). It initiates interactions between the" exact="DENV" post="envelope protein and the host cell (Figure 3). HS"/>
  <result pre="heads exhibits a strong inhibitory effect on infections caused by" exact="DENV" post="[74]. Chondroitin sulfate, a curdlan sulfate that inhibits all"/>
  <result pre="DENV [74]. Chondroitin sulfate, a curdlan sulfate that inhibits all" exact="DENV" post="serotypes, has been found in baby hamster kidney 21"/>
  <result pre="infectivity (Figure 3) [73,89]. Although the role of DC-SIGN in" exact="DENV" post="entry remains controversial [90,91,92], many authors posit that DENV"/>
  <result pre="in DENV entry remains controversial [90,91,92], many authors posit that" exact="DENV" post="is handed over to another unidentified co-receptor for movement"/>
  <result pre="Findings yielded by a large number of studies indicate that" exact="DENV" post="can recognize cell surface DC-SIGN, as well as move"/>
  <result pre="viral attachment, resulting in entry into the cell [89,93]. As" exact="DENV" post="can pass to clathrin-coated structures (CCS) through virus receptor"/>
  <result pre="complexes [22], receptors that mediate DC-SIGN are potential targets for" exact="DENV" post="antiviral treatment. Several compounds, such as glycomimetic DC-SIGN ligand"/>
  <result pre="(Table 1), were found to act as strong inhibitors of" exact="DENV" post="infection in DC-transfected cells. These findings can potentially be"/>
  <result pre="efficiency of a wide spectrum of antiviral therapies to block" exact="DENV" post="virus uptake. 4.3. Other Possible Receptors Viral attachment to"/>
  <result pre="of higher affinity receptors may then be recruited to permit" exact="DENV" post="entry because of the diverse tissue tropism of the"/>
  <result pre="because of the diverse tissue tropism of the virus [94]." exact="DENV" post="uses two pathways to enter DCs, whereby infection can"/>
  <result pre="of antibodies grant an alternative entry pathway of DENV, where" exact="DENV" post="enters monocytes, macrophages, and dendritic cells through the activating"/>
  <result pre="monocytes, macrophages, and dendritic cells through the activating FcɣRs [95]." exact="DENV" post="can enter cells via cellular attachment molecules’ TIM and"/>
  <result pre="responsible for the engulfment and removal of apoptotic cells. Since" exact="DENV" post="is a virus that exposes PtdSer in its membrane,"/>
  <result pre="and GRP-78 are known as a receptor complex, which allows" exact="DENV" post="entry into human cells from hepatic, neural, and monocytic"/>
  <result pre="class B type I (SCARB1), also known as SR-BI, promotes" exact="DENV" post="infections, necessitating further research in order to elucidate the"/>
  <result pre="into the host, as well as for replication and assembly." exact="DENV" post="dominates some processes to manipulate the host cell proteins"/>
  <result pre="as furin and signalase, have been used to cleave the" exact="DENV" post="RNA genome co- and post-translationally and were translated as"/>
  <result pre="protease required for virus polyprotein formation is a basis of" exact="DENV" post="replication, it can be a strong target for antiviral"/>
  <result pre="of the host cell, where it assists in cleaving the" exact="DENV" post="prM proteins, resulting in the formation of mature active"/>
  <result pre="the virion M protein that plays an important role during" exact="DENV" post="infections [99,103]. The signal peptidase on endoplasmic reticulum (ER)"/>
  <result pre="target. 5.2. Targeting Host Kinases Host kinases are involved in" exact="DENV" post="assembly and secretion. Protein kinase inhibits the dengue replication"/>
  <result pre="MAP kinase-activated protein kinase 5 (MAPKAPK5) kinase activity and inhibit" exact="DENV" post="propagation [108]. GNF-2 and imatinib inhibit DENV but are"/>
  <result pre="activity and inhibit DENV propagation [108]. GNF-2 and imatinib inhibit" exact="DENV" post="but are mediated by cellular Abl kinases [109]. Many"/>
  <result pre="AR-12 inhibits PI3K/JAKT pathway by expressing GRP-78 for all four" exact="DENV" post="serotypes. Sunitinib and erlotinib, as well as isothiazolo[5,4-b] pyridines"/>
  <result pre="pyridazine, are inhibitors of AAK1 and GAK pathways that inhibit" exact="DENV" post="replication, whereas U0126 inhibits the ERK pathway to reduce"/>
  <result pre="N-linked oligosaccharides of the viral prM and E glycoproteins [110]." exact="DENV" post="structural protein prM and E glycoproteins are translocated into"/>
  <result pre="reticulum chaperones (calnexin or calreticulin) for proper folding [113]. As" exact="DENV" post="prME heterodimer formation is not influenced by the inhibition"/>
  <result pre="been shown that the folding, stability, secretion, and activity of" exact="DENV" post="glycoproteins in the ER depends on the trimming of"/>
  <result pre="celgosivir have shown to causing an improved survival rate in" exact="DENV" post="infected mouse. The efficacy analyses were performed in patients"/>
  <result pre="to decrease mortality in an &quot;antibody-dependent enhancement�? model of secondary" exact="DENV" post="infection [117]. It is also noteworthy that α-glucosidase substrate"/>
  <result pre="cell signals are generated to block the dissemination of DENV." exact="DENV" post="causes acute disease without persistent infection. All virus strains"/>
  <result pre="strategies that bypass the innate and adaptive immune response. Therefore," exact="DENV" post="does not escape the host defense mechanism. Innate immunity"/>
  <result pre="Hence, a better understanding of the host immune response during" exact="DENV" post="infection and the evasion mechanisms would have great importance"/>
  <result pre="potential antiviral production. 6.1. Targeting Host Immune Factors Involved in" exact="DENV" post="Sensing Viral pathogenic factors can be recognized through the"/>
  <result pre="lectin domain family 5 member A (CLEC5A) does not block" exact="DENV" post="infection [122]. Other important molecules such as toll-like receptors"/>
  <result pre="as toll-like receptors (TLR3) also sense dsRNA and can restrict" exact="DENV" post="replication in different cell lineages [123,124,125]. DENV produces excess"/>
  <result pre="and can restrict DENV replication in different cell lineages [123,124,125]." exact="DENV" post="produces excess IFN-I (essential for DENV-induced production) through toll-like"/>
  <result pre="toll-like receptors 7 (TLR7) in plasmacytoid-DC, which can also restrict" exact="DENV" post="replication in different cell lineages, as TLR3 [126]. Additionally,"/>
  <result pre="TLR3 [126]. Additionally, increasing inflammatory and humoral responses that decrease" exact="DENV" post="replication have been found, such as when TLR3 and"/>
  <result pre="into rhesus macaques aided in enhanced antiviral mechanisms during primary" exact="DENV" post="infection [127]. Gene expression analysis indicates that RIG-I and"/>
  <result pre="beta (IFN-β) promoters, resulting in impaired replication of DENV. Additionally," exact="DENV" post="with double or single RIG-I/MDA5-deficient fibroblasts triggers both responses"/>
  <result pre="detection of antibodies via RNA sensors (for examples RIG-I) enhanced" exact="DENV" post="infection by tissue-resident mast cells that produce type IFN-I,"/>
  <result pre="MDA5, and TLR3 sensors (major PRRs recognize innate responses to" exact="DENV" post="infection), contributing to impairing DENV replication in vitro [130]."/>
  <result pre="PRRs recognize innate responses to DENV infection), contributing to impairing" exact="DENV" post="replication in vitro [130]. Activation of these major pattern"/>
  <result pre="[130]. Activation of these major pattern recognition receptors (PRRs) by" exact="DENV" post="generates a strong type of IFN-I response during human"/>
  <result pre="reported [131]. Extant evidence (experimented upon mice) further indicates that" exact="DENV" post="primary infection utilizes the interferon α/β receptor (IFNAR)-dependent (including"/>
  <result pre="the latter antiviral process—aiding virus propagation and disease control. In" exact="DENV" post="primary infection, cells typically utilize both mechanisms [132,133]. Anti-CLEC5A"/>
  <result pre="primary infection, cells typically utilize both mechanisms [132,133]. Anti-CLEC5A blocks" exact="DENV" post="by releasing pro-inflammatory cytokines and does not affect IFN-I"/>
  <result pre="IFN-I production in the infected cells [134]. As CLEC5A blocks" exact="DENV" post="infections, future studies are necessary to enhance CLEC5A activation."/>
  <result pre="(IFN)-γ, all of which are responsible for primary and secondary" exact="DENV" post="infection in humans, are excessively elevated and have been"/>
  <result pre="Cytokines are not responsible in causing any primary and secondary" exact="DENV" post="infections in humans. Cytokine IFN-γ production in the host"/>
  <result pre="production in the host cell plays protective roles during primary" exact="DENV" post="infection. In primary DENV infections, production of IL-12 and"/>
  <result pre="cell plays protective roles during primary DENV infection. In primary" exact="DENV" post="infections, production of IL-12 and IL-18 proinflammatory cytokines precede"/>
  <result pre="oxide production that assists the host in resistance against primary" exact="DENV" post="infection [145], which was previously found to inhibit DENV"/>
  <result pre="primary DENV infection [145], which was previously found to inhibit" exact="DENV" post="replication [146]. Sustained IFN-γ production is necessary during the"/>
  <result pre="can be a potential target for the host to control" exact="DENV" post="replication and resistance to infection. Enhanced proinflammatory cytokine TNF-α"/>
  <result pre="contain higher amounts of TNF-α after ex vivo stimulation with" exact="DENV" post="antigens [148]. Hence, the blocking of enhanced proinflammatory cytokine"/>
  <result pre="is indicative of a more severe disease form during primary" exact="DENV" post="infections [138]. Experiments have shown that DENV primary infections"/>
  <result pre="form during primary DENV infections [138]. Experiments have shown that" exact="DENV" post="primary infections were less severe in MIF−/− mice, and"/>
  <result pre="proinflammatory cytokines TNF-α and MIF during the host response to" exact="DENV" post="infection favors more severe disease [152]. The chemokine system"/>
  <result pre="chemokine system that plays a protective and pathologic role during" exact="DENV" post="infections produces CXCL10 and activates CXCR3 (C-X-C chemokine receptor"/>
  <result pre="(C-X-C chemokine receptor type 3) to improve host resistance against" exact="DENV" post="infection [7]. Clinical studies in endemic areas indicated the"/>
  <result pre="in endemic areas indicated the presence of a correlation between" exact="DENV" post="outcome and the level of CCL2, 3, 4 concentrations"/>
  <result pre="2 and type 4 (CCR2−/−and CCR4−/−) knockout mice with primary" exact="DENV" post="infection. However, no difference in viral load has been"/>
  <result pre="CCR2 and CCR4 cause infection rather than providing protection against" exact="DENV" post="infection [154]. Cellular populations are also important for DENV"/>
  <result pre="against DENV infection [154]. Cellular populations are also important for" exact="DENV" post="infection. For example, cluster of differentiation 8 (CD8+) T"/>
  <result pre="leakage by stabilization of endothelial cell development is important for" exact="DENV" post="infection prevention [201]. The MIF inhibitor ISO-1 reduces permeability"/>
  <result pre="endothelial stabilization [205]. 6.4. Targeting Immune Factor Progress Disease after" exact="DENV" post="Infection Platelet-activating factor receptors (PAFR) released from macrophages, which"/>
  <result pre="advantages over synthetic drug design [207] and also tested as" exact="DENV" post="inhibitors. Interferon type I [129], human heme oxygenase I,"/>
  <result pre="helicase with zinc linger 2 [194] are other examples of" exact="DENV" post="inhibitors that have been experimentally studied to ascertain their"/>
  <result pre="arise in the way of host inhibition processes that interrupt" exact="DENV" post="replication along with infections. Host metabolic pathways serve as"/>
  <result pre="DENV. For example, the primary glycolysis is conservatively required by" exact="DENV" post="and exogenous glucose, and glutamine deprivation decreases DENV production,"/>
  <result pre="required by DENV and exogenous glucose, and glutamine deprivation decreases" exact="DENV" post="production, which could lead to the development of novel"/>
  <result pre="to the role of lipid and fatty acid metabolism during" exact="DENV" post="infection, and the extant findings indicate that modulating lipid"/>
  <result pre="biosynthesis pathways of the host supply necessary nucleosides required for" exact="DENV" post="replication. Hence, targeting the host nucleoside biosynthesis pathways can"/>
  <result pre="biosynthesis pathways can assist in blocking the essential functions of" exact="DENV" post="as another avenue for antiviral drug development. In the"/>
  <result pre="continue the viral life cycle. This process can occur in" exact="DENV" post="through the interaction between viral surface proteins and host"/>
  <result pre="genome release into the cytoplasm. If the early steps of" exact="DENV" post="infection cycle can be blocked by targeting host attachment"/>
  <result pre="development of antiviral drugs. Without utilizing host proteins and enzymes," exact="DENV" post="would be unable to propagate rapidly in host cells."/>
  <result pre="cells. Numerous host proteins are found to be essential in" exact="DENV" post="replication. For example, host proteases aid in the RNA"/>
  <result pre="genome cleavage and polyprotein formation, while host kinases help in" exact="DENV" post="assembly, and glucosidase is used in DENV maturation and"/>
  <result pre="kinases help in DENV assembly, and glucosidase is used in" exact="DENV" post="maturation and folding. Every single step mentioned utilizes host"/>
  <result pre="proteins and enzymes, which are the most important factors for" exact="DENV" post="multiplications. Hence, targeting one of these can reduce DENV"/>
  <result pre="for DENV multiplications. Hence, targeting one of these can reduce" exact="DENV" post="production and may lead to an effective antiviral drug."/>
  <result pre="drug. The inflammatory response is activated in host cells during" exact="DENV" post="infection to clear the pathogen from the host immune"/>
  <result pre="immune system. Whenever the host senses the presence of the" exact="DENV" post="virus, activation of innate and inflammatory pathways occurs as"/>
  <result pre="discussed in this work can yield more comprehensive knowledge about" exact="DENV" post="and related host factors that can be utilized in"/>
  <result pre="1.BuchmeierM.J.PetersC.J.de LaT.J.F.V.Arenaviridae: The Virus and Their ReplicationFields Virol.200717921827 2.TelesF.R.R.PrazeresD.M.F.Lima-FilhoJ.L.Trends in" exact="Dengue" post="DiagnosisRev. Med. Virol.20051528730210.1002/rmv.46115672450 3.OliveiraE.R.A.Mohana-BorgesR.de AlencastroR.B.HortaB.A.C.The Flavivirus Capsid Protein: Structure,"/>
  <result pre="Function and Perspectives towards Drug DesignVirus Res.201722711512310.1016/j.virusres.2016.10.00527751882 4.MillerN.Recent Progress in" exact="Dengue" post="Vaccine Research and DevelopmentCurr. Opin. Mol.2010123138 5.FontaineK.A.SanchezE.L.CamardaR.LagunoffM.Dengue Virus Induces"/>
  <result pre="and Requires Glycolysis for Optimal ReplicationJ. Virol.2015892358236610.1128/JVI.02309-1425505078 6.WhiteheadS.S.BlaneyJ.E.DurbinA.P.MurphyB.R.Prospects for a" exact="Dengue" post="Virus VaccineNat. Rev. Microbiol.2007551852810.1038/nrmicro169017558424 7.HalsteadS.B.Antibody, Macrophages, Dengue Virus Infection,"/>
  <result pre="6.WhiteheadS.S.BlaneyJ.E.DurbinA.P.MurphyB.R.Prospects for a Dengue Virus VaccineNat. Rev. Microbiol.2007551852810.1038/nrmicro169017558424 7.HalsteadS.B.Antibody, Macrophages," exact="Dengue" post="Virus Infection, Shock, and Hemorrhage: A Pathogenetic CascadeRev. Infect."/>
  <result pre="of dengue feverInfect. Dis.1907444047510.1093/infdis/4.3.440 14.ClelandJ.B.BradleyB.MacDonaldW.Further Experiments in the Etiology of" exact="Dengue" post="FeverJ. Hyg.19191821725410.1017/S002217240000747620474685 15.NishiuraH.HalsteadS.B.Natural History of Dengue Virus (DENV) 1"/>
  <result pre="in the Etiology of Dengue FeverJ. Hyg.19191821725410.1017/S002217240000747620474685 15.NishiuraH.HalsteadS.B.Natural History of" exact="Dengue" post="Virus (DENV) 1 and DENV 4 InfectionsJ. Infect. Dis.20071951007101310.1086/51182517330791"/>
  <result pre="FeverJ. Hyg.19191821725410.1017/S002217240000747620474685 15.NishiuraH.HalsteadS.B.Natural History of Dengue Virus (DENV) 1 and" exact="DENV" post="4 InfectionsJ. Infect. Dis.20071951007101310.1086/51182517330791 16.SilerJ.F.HallM.W.HitchensA.P.Dengue: Its History, Epidemiology, Mechanism"/>
  <result pre="19.KonishiE.KunoG.In Memoriam: Susumu Hotta (1918–2011)Emerg. Infect. Dis.20131984384510.3201/eid1905.IM098623697347 20.MessinaJ.P.BradyO.J.ScottT.W.ZouC.PigottD.M.DudaK.A.SimmonsC.P.Global Spread of" exact="Dengue" post="Virus Types: Mapping the 70 Year HistoryTrends Microbiol.20142213814610.1016/j.tim.2013.12.01124468533 21.EbiK.L.NealonJ.Dengue"/>
  <result pre="Causes, Complications, and Vaccine StrategiesJ. Immunol. Res.2016201611410.1155/2016/680309827525287 24.ChenL.H.MaryE.Non-Vector Transmission of" exact="Dengue" post="and Other Mosquito-Borne FlavivirusesDengue Bull.2005291831 25.WazieresD.EliteA.S.ClinicalM.J.Nosocomial transmission of dengue"/>
  <result pre="transmission of dengue from a needlestick injuryLancet199835149810.1016/S0140-6736(05)78686-4 26.HirschJ.F.DeschampsC.LhuillierM.Transmission MŽtropolitaine d’une" exact="Dengue" post="Par Inoculation Accidentelle HospitalièreAnn. Med. Intern.1990141629 27.LanggartnerJ.AudebertF.SchölmerichJ.GlückT.Dengue Virus Infection"/>
  <result pre="29.WagnerD.De WithK.HuzlyD.HufertF.WeidmannM.BreisingerS.EppingerS.KernW.V.BauerT.M.Nosocomial Acquisition of DengueEmerg. Infect. Dis.2004101872187310.3201/eid1010.03103715504282 30.BerberianG.FarinaD.RosanovaM.T.HidalgoS.EnriaD.MitchenkoA.MorenoJ.SánchezI.S.Dengue Perinatal; Perinatal" exact="Dengue" post="InfectionArch. Argent. Pediatr.201110923223621660390 31.Rigau-PérezJ.G.VorndamA.V.ClarkG.G.The Dengue and Dengue Hemorrhagic Fever"/>
  <result pre="Infect. Dis.2004101872187310.3201/eid1010.03103715504282 30.BerberianG.FarinaD.RosanovaM.T.HidalgoS.EnriaD.MitchenkoA.MorenoJ.SánchezI.S.Dengue Perinatal; Perinatal Dengue InfectionArch. Argent. Pediatr.201110923223621660390 31.Rigau-PérezJ.G.VorndamA.V.ClarkG.G.The" exact="Dengue" post="and Dengue Hemorrhagic Fever Epidemic in Puerto Rico, 1994–1995Am."/>
  <result pre="30.BerberianG.FarinaD.RosanovaM.T.HidalgoS.EnriaD.MitchenkoA.MorenoJ.SánchezI.S.Dengue Perinatal; Perinatal Dengue InfectionArch. Argent. Pediatr.201110923223621660390 31.Rigau-PérezJ.G.VorndamA.V.ClarkG.G.The Dengue and" exact="Dengue" post="Hemorrhagic Fever Epidemic in Puerto Rico, 1994–1995Am. J. Trop."/>
  <result pre="in Puerto Rico, 1994–1995Am. J. Trop. Med. Hyg.200164677410.4269/ajtmh.2001.64.6711425166 32.ChenL.H.WilsonM.E.Transmission of" exact="Dengue" post="Virus without a Mosquito Vector: Nosocomial Mucocutaneous Transmission and"/>
  <result pre="et Quo Vadis?Viruses201131562160810.3390/v309156221994796 34.HolmesE.C.TwiddyS.S.The Origin, Emergence and Evolutionary Genetics of" exact="Dengue" post="VirusInfect. Genet. Evol.20033192810.1016/S1567-1348(03)00004-212797969 35.DialloM.BaY.SallA.A.DiopO.M.NdioneJ.A.MondoM.GiraultL.MathiotC.Amplification of the Sylvatic Cycle of"/>
  <result pre="Dengue VirusInfect. Genet. Evol.20033192810.1016/S1567-1348(03)00004-212797969 35.DialloM.BaY.SallA.A.DiopO.M.NdioneJ.A.MondoM.GiraultL.MathiotC.Amplification of the Sylvatic Cycle of" exact="Dengue" post="Virus Type 2, Senegal, 1999-2000: Entomologic Findings and Epidemiologic"/>
  <result pre="Entomologic Findings and Epidemiologic ConsiderationsEmerg. Infect. Dis.2003936236710.3201/eid0903.02021912643833 36.HervyJ.P.LegrosF.RocheJ.C.MontenyN.DiacoB.Circulation Du Virus" exact="Dengue" post="2 Dans Plusieurs Milieux Boisés des Savanes Soudaniennes de"/>
  <result pre="and yellow feverComp. Immunol. Microbiol. Infect. Dis.19911491910.1016/0147-9571(91)90036-D1905605 38.RobinY.CornetM.HemeG.Le GonidecG.Isolation of" exact="Dengue" post="Virus from Senegal/Isolement Du Virus de La Dengue Au"/>
  <result pre="GonidecG.Isolation of Dengue Virus from Senegal/Isolement Du Virus de La" exact="Dengue" post="Au SenegalAnn. Virol. E1980131149154 39.RocheJ.C.CordellierR.HervyJ.P.DigoutteJ.P.MontenyN.Isolement de 96 Souches de"/>
  <result pre="Au SenegalAnn. Virol. E1980131149154 39.RocheJ.C.CordellierR.HervyJ.P.DigoutteJ.P.MontenyN.Isolement de 96 Souches de Virus" exact="Dengue" post="2 à Partir de Moustiques Capturés En Cote-d’ivoire et"/>
  <result pre="IVW.C.BennettK.E.Gorrochótegui-EscalanteN.Barillas-MuryC.V.Fernández-SalasI.MuñozM.D.L.Farfán-AléJ.A.OlsonK.E.BeatyB.J.Flavivirus Susceptibility in Aedes AegyptiArch. Med. Res.20023337938810.1016/S0188-4409(02)00373-912234528 42.YuwonoJ.SuharyonoW.KoimanI.TsuchiyaY.TagayaI.Seroepidemiological Survey on" exact="Dengue" post="and Japanese Encephalitis Virus Infections in Asian MonkeysSouth. Asian"/>
  <result pre="J. Trop. Med. Public Health198415194200 43.RosenL.Observations on the Epidemiology of" exact="Dengue" post="in PanamaAm. J. Epidemiol.195868455810.1093/oxfordjournals.aje.a119948 44.RobertsD.PeytonE.PinheiroF.BalderramaF.Associations of Arbovirus Vectors with"/>
  <result pre="45.GermainM.MouchetJ.CordellierR.ChippauxA.CornetM.HerveJ.P.SureauP.FabreJ.RobinY.Epidemiology of yellow fever in AfricaMed. Infect. Dis.197886977 46.RudnickA.L.B.E.R.T.Ecology of" exact="Dengue" post="VirusAsian J. Infect. Dis.19782156160 47.FreierJ.E.RosenL.Vertical Transmission of Dengue Viruses"/>
  <result pre="46.RudnickA.L.B.E.R.T.Ecology of Dengue VirusAsian J. Infect. Dis.19782156160 47.FreierJ.E.RosenL.Vertical Transmission of" exact="Dengue" post="Viruses by Aedes MediovittatusAm. J. Trop. Med. Hyg.19883921822210.4269/ajtmh.1988.39.2183407842 48.collab:"/>
  <result pre="by Aedes MediovittatusAm. J. Trop. Med. Hyg.19883921822210.4269/ajtmh.1988.39.2183407842 48.collab: WHODengue and" exact="Dengue" post="Haemorrhagic Fever. 1990–1994Relev. Epidemiol. Hebd.199570334335 49.GublerD.J.Dengue and Dengue Hemorrhagic"/>
  <result pre="WHODengue and Dengue Haemorrhagic Fever. 1990–1994Relev. Epidemiol. Hebd.199570334335 49.GublerD.J.Dengue and" exact="Dengue" post="Hemorrhagic Fever, 1996Epidemiol. Bull.1996171214 50.TaiA.W.BenitaY.PengL.F.KimS.SakamotoN.XavierR.J.ChungR.T.A functional genomic screen identifies"/>
  <result pre="ONE20116e2497010.1371/journal.pone.002497021949814 58.KrishnanM.N.NgA.SukumaranB.GilfoyF.D.UchilP.D.SultanaH.BrassA.L.AdametzR.TsuiM.QianF.et al.RNA Interference Screen for Human Genes Associated with" exact="West Nile" post="Virus InfectionNature200845524224510.1038/nature0720718690214 59.SessionsO.M.BarrowsN.J.Souza-NetoJ.A.RobinsonT.J.HersheyC.L.RodgersM.A.RamirezJ.L.DimopoulosG.YangP.L.PearsonJ.L.et al.Discovery of Insect and Human Dengue"/>
  <result pre="West Nile Virus InfectionNature200845524224510.1038/nature0720718690214 59.SessionsO.M.BarrowsN.J.Souza-NetoJ.A.RobinsonT.J.HersheyC.L.RodgersM.A.RamirezJ.L.DimopoulosG.YangP.L.PearsonJ.L.et al.Discovery of Insect and Human" exact="Dengue" post="Virus Host FactorsNature20094581047105010.1038/nature0796719396146 60.JordanT.X.RandallG.Flavivirus Modulation of Cellular MetabolismCurr. Opin."/>
  <result pre="Regulates Lipid MetabolismCell Host Microbe2010842243210.1016/j.chom.2010.10.00621075353 64.KhakpoorA.PanyasrivanitM.WikanN.SmithD.R.A Role for Autophagolysosomes in" exact="Dengue" post="Virus 3 Production in HepG2 CellsJ. Gen. Virol.2009901093110310.1099/vir.0.007914-019264601 65.LeeY.R.HuH.Y.KuoS.H.LeiH.Y.LinY.S.YehT.M.LiuC.C.LiuH.S.Dengue"/>
  <result pre="in Vivo StudyJ. Biomed. Sci.2013206510.1186/1423-0127-20-6524011333 66.MateoR.NagamineC.M.SpagnoloJ.MéndezE.RaheM.GaleM.YuanJ.KirkegaardK.Inhibition of Cellular Autophagy Deranges" exact="Dengue" post="Virion MaturationJ. Virol.2013871312132110.1128/JVI.02177-1223175363 67.JordanT.X.RandallG.Flaviviruses and AutophagyAutophagy, Infection, and the"/>
  <result pre="&amp;amp; Sons, Inc.Hoboken, NJ, USA201581100 68.RothwellC.LeBretonA.Young NgC.LimJ.Y.H.LiuW.VasudevanS.LabowM.GuF.GaitherL.A.Cholesterol Biosynthesis Modulation Regulates" exact="Dengue" post="Viral ReplicationVirology200938981910.1016/j.virol.2009.03.02519419745 69.WangQ.Y.BushellS.QingM.XuH.Y.BonaviaA.NunesS.ZhouJ.PohM.K.Florez de SessionsP.NiyomrattanakitP.et al.Inhibition of Dengue Virus"/>
  <result pre="Modulation Regulates Dengue Viral ReplicationVirology200938981910.1016/j.virol.2009.03.02519419745 69.WangQ.Y.BushellS.QingM.XuH.Y.BonaviaA.NunesS.ZhouJ.PohM.K.Florez de SessionsP.NiyomrattanakitP.et al.Inhibition of" exact="Dengue" post="Virus through Suppression of Host Pyrimidine BiosynthesisJ. Virol.2011856548655610.1128/JVI.02510-1021507975 70.LiuS.NeidhardtE.A.GrossmanT.H.OcainT.ClardyJ.Structures"/>
  <result pre="for the Productive Infection of Human Dendritic Cells by Mosquito-Cell-Derived" exact="Dengue" post="VirusesEMBO Rep.2003472372810.1038/sj.embor.embor86612783086 73.TassaneetrithepB.BurgessT.H.Granelli-PipernoA.TrumpfhellerC.FinkeJ.SunW.EllerM.A.PattanapanyasatK.SarasombathS.BirxD.L.et al.DC-SIGN (CD209) Mediates Dengue Virus Infection"/>
  <result pre="Cells by Mosquito-Cell-Derived Dengue VirusesEMBO Rep.2003472372810.1038/sj.embor.embor86612783086 73.TassaneetrithepB.BurgessT.H.Granelli-PipernoA.TrumpfhellerC.FinkeJ.SunW.EllerM.A.PattanapanyasatK.SarasombathS.BirxD.L.et al.DC-SIGN (CD209) Mediates" exact="Dengue" post="Virus Infection of Human Dendritic CellsJ. Exp. Med.200319782382910.1084/jem.2002184012682107 74.HungJ.J.HsiehM.T.YoungM.J.KaoC.L.KingC.C.ChangW.An"/>
  <result pre="Exp. Med.200319782382910.1084/jem.2002184012682107 74.HungJ.J.HsiehM.T.YoungM.J.KaoC.L.KingC.C.ChangW.An External Loop Region of Domain III of" exact="Dengue" post="Virus Type 2 Envelope Protein Is Involved in Serotype-Specific"/>
  <result pre="78 (BiP) as a Liver Cell Expressed Receptor Element for" exact="Dengue" post="Virus Serotype 2Arch. Virol.200414991592710.1007/s00705-003-0263-x15098107 76.MeertensL.CarnecX.LecoinM.P.RamdasiR.Guivel-BenhassineF.LewE.LemkeG.SchwartzO.AmaraA.The TIM and TAM Families"/>
  <result pre="Virol.200414991592710.1007/s00705-003-0263-x15098107 76.MeertensL.CarnecX.LecoinM.P.RamdasiR.Guivel-BenhassineF.LewE.LemkeG.SchwartzO.AmaraA.The TIM and TAM Families of Phosphatidylserine Receptors Mediate" exact="Dengue" post="Virus EntryCell Host Microbe20121254455710.1016/j.chom.2012.08.00923084921 77.IchiyamaK.Gopala ReddyS.B.ZhangL.F.ChinW.X.MuschinT.HeinigL.SuzukiY.NanjundappaH.YoshinakaY.RyoA.et al.Sulfated Polysaccharide, Curdlan"/>
  <result pre="Curdlan Sulfate, Efficiently Prevents Entry/Fusion and Restricts Antibody-Dependent Enhancement of" exact="Dengue" post="Virus Infection In Vitro: A Possible Candidate for Clinical"/>
  <result pre="Negl. Trop. Dis.20137e218810.1371/journal.pntd.000218823658845 78.KatoD.EraS.WatanabeI.AriharaM.SugiuraN.KimataK.SuzukiY.MoritaK.HidariK.I.P.J.SuzukiT.Antiviral Activity of Chondroitin Sulphate E Targeting" exact="Dengue" post="Virus Envelope ProteinAntivir. Res.20108823624310.1016/j.antiviral.2010.09.00220851716 79.ChenY.MaguireT.HilemanR.FrommJ.EskoJ.LinhardtR.MarksR.Dengue Virus Infectivity Depends Envelope"/>
  <result pre="Med.1997386687110.1038/nm0897-8669256277 80.LeeE.PavyM.YoungN.FreemanC.LobigsM.Antiviral Effect of the Heparan Sulfate Mimetic, PI-88, against" exact="Dengue" post="and Encephalitic FlavivirusesAntivir. Res.200669313810.1016/j.antiviral.2005.08.00616309754 81.HungS.L.LeeP.L.ChenH.W.ChenL.K.KaoC.L.KingC.C.Analysis of the Steps Involved"/>
  <result pre="and Encephalitic FlavivirusesAntivir. Res.200669313810.1016/j.antiviral.2005.08.00616309754 81.HungS.L.LeeP.L.ChenH.W.ChenL.K.KaoC.L.KingC.C.Analysis of the Steps Involved in" exact="Dengue" post="Virus Entry into Host CellsVirology199925715616710.1006/viro.1999.963310208929 82.HidariK.I.P.J.TakahashiN.AriharaM.NagaokaM.MoritaK.SuzukiT.Structure and Anti-Dengue Virus"/>
  <result pre="Biophys. Res. Commun.2008376919510.1016/j.bbrc.2008.08.10018762172 83.VervaekeP.AlenM.NoppenS.ScholsD.OresteP.LiekensS.Sulfated Escherichia Coli K5 Polysaccharide Derivatives Inhibit" exact="Dengue" post="Virus Infection of Human Microvascular Endothelial Cells by Interacting"/>
  <result pre="Activity of Carbohydrate-Binding Agents and the Role of DC-SIGN in" exact="Dengue" post="Virus InfectionVirology2009387677510.1016/j.virol.2009.01.04319264337 86.TalaricoL.B.DamonteE.B.Interference in Dengue Virus Adsorption and Uncoating"/>
  <result pre="the Role of DC-SIGN in Dengue Virus InfectionVirology2009387677510.1016/j.virol.2009.01.04319264337 86.TalaricoL.B.DamonteE.B.Interference in" exact="Dengue" post="Virus Adsorption and Uncoating by CarrageenansVirology200736347348510.1016/j.virol.2007.01.04317337028 87.Reyes-del ValleJ.Salas-BenitoJ.Soto-AcostaR.del AngelR.M.Dengue"/>
  <result pre="Cell BiologyJ. Leukoc. Biol.2002271921931 89.LiuP.RidillaM.PatelP.BettsL.GallichotteE.ShahidiL.ThompsonN.L.JacobsonK.Beyond Attachment: Roles of DC-SIGN in" exact="Dengue" post="Virus InfectionTraffic20171821823110.1111/tra.1246928128492 90.FlipseJ.WilschutJ.TrafficJ.S.Molecular mechanisms involved in antibody-dependent enhancement of"/>
  <result pre="91.LozachP.Y.BurleighL.StaropoliI.Navarro-SanchezE.HarriagueJ.VirelizierJ.L.ReyF.A.DesprèsP.Arenzana-SeisdedosF.AmaraA.Dendritic Cell-Specific Intercellular Adhesion Molecule 3-Grabbing Non-Integrin (DC-SIGN)-Mediated Enhancement of" exact="Dengue" post="Virus Infection Is Independent of DC-SIGN Internalization SignalsJ. Biol."/>
  <result pre="of a Putative Coreceptor on Vero Cells That Participates in" exact="Dengue" post="4 Virus InfectionJ. Virol.2002757818782710.1128/JVI.75.17.7818-7827.200111483725 95.BoonnakK.SlikeB.M.BurgessT.H.MasonR.M.WuS.-J.SunP.PorterK.RudimanI.F.YuwonoD.PuthavathanaP.et al.Role of Dendritic Cells"/>
  <result pre="Virol.2002757818782710.1128/JVI.75.17.7818-7827.200111483725 95.BoonnakK.SlikeB.M.BurgessT.H.MasonR.M.WuS.-J.SunP.PorterK.RudimanI.F.YuwonoD.PuthavathanaP.et al.Role of Dendritic Cells in Antibody-Dependent Enhancement of" exact="Dengue" post="Virus InfectionJ. Virol.2008823939395110.1128/JVI.02484-0718272578 96.BhattacharyyaS.ZagórskaA.LewE.D.ShresthaB.RothlinC.V.NaughtonJ.DiamondM.S.LemkeG.YoungJ.A.T.Enveloped Viruses Disable Innate Immune Responses"/>
  <result pre="Protein 90 and Heat Shock Protein 70 Are Components of" exact="Dengue" post="Virus Receptor Complex in Human CellsJ. Virol.2005794557456710.1128/JVI.79.8.4557-4567.200515795242 99.ElshuberS.AllisonS.L.HeinzF.X.MandlC.W.Cleavage of"/>
  <result pre="BHK-21 Cells by Tick-Borne Encephalitis VirusJ. Gen. Virol.20038418319110.1099/vir.0.18723-012533715 100.ArakakiT.L.FangN.X.FairlieD.P.YoungP.R.MartinJ.L.Catalytically Active" exact="Dengue" post="Virus NS3 Protease Forms Aggregates That Are Separable by"/>
  <result pre="dengue virus diseasesFEBS J.20072742986300210.1111/j.1742-4658.2007.05831.x17509079 102.GouveaI.E.IzidoroM.A.JudiceW.A.S.CezariM.H.S.CaliendoG.SantagadaV.dos SantosC.N.D.QueirozM.H.JulianoM.A.YoungP.R.et al.Substrate Specificity of Recombinant" exact="Dengue" post="2 Virus NS2B-NS3 Protease: Influence of Natural and Unnatural"/>
  <result pre="Res.201714317618510.1016/j.antiviral.2017.03.02628389141 106.ChuJ.J.H.YangP.L.C-Src Protein Kinase Inhibitors Block Assembly and Maturation of" exact="Dengue" post="VirusProc. Natl. Acad. Sci. USA20071043520352510.1073/pnas.061168110417360676 107.de WispelaereM.LaCroixA.J.YangP.L.The Small Molecules"/>
  <result pre="Sci. USA20071043520352510.1073/pnas.061168110417360676 107.de WispelaereM.LaCroixA.J.YangP.L.The Small Molecules AZD0530 and Dasatinib Inhibit" exact="Dengue" post="Virus RNA Replication via Fyn KinaseJ. Virol.2013877367738110.1128/JVI.00632-1323616652 108.AnwarA.HosoyaT.LeongK.M.OnogiH.OkunoY.HiramatsuT.KoyamaH.SuzukiM.HagiwaraM.Garcia-BlancoM.A.The Kinase"/>
  <result pre="Replication via Fyn KinaseJ. Virol.2013877367738110.1128/JVI.00632-1323616652 108.AnwarA.HosoyaT.LeongK.M.OnogiH.OkunoY.HiramatsuT.KoyamaH.SuzukiM.HagiwaraM.Garcia-BlancoM.A.The Kinase Inhibitor Sfv785 Dislocates" exact="Dengue" post="Virus Envelope Protein from the Replication Complex and Blocks"/>
  <result pre="Complex and Blocks Virus AssemblyPLoS ONE20116e2324610.1371/journal.pone.002324621858043 109.ClarkM.J.MiduturuC.SchmidtA.G.ZhuX.PittsJ.D.WangJ.PotisoponS.ZhangJ.WojciechowskiA.Hann ChuJ.J.et al.GNF-2 Inhibits" exact="Dengue" post="Virus by Targeting Abl Kinases and the Viral e"/>
  <result pre="the Viral e ProteinCell Chem. Biol.20162344345210.1016/j.chembiol.2016.03.01027105280 110.CourageotM.P.FrenkielM.P.Dos SantosC.D.DeubelV.DesprèsP.Alpha-Glucosidase Inhibitors Reduce" exact="Dengue" post="Virus Production by Affecting the Initial Steps of Virion"/>
  <result pre="Expression, And ReplicationAnnu. Rev. Microbiol.19904464968810.1146/annurev.mi.44.100190.0032452174669 112.WhitbyK.PiersonT.C.GeissB.LaneK.EngleM.ZhouY.DomsR.W.DiamondM.S.Castanospermine, a Potent Inhibitor of" exact="Dengue" post="Virus Infection In Vitro and In VivoJ. Virol.2005798698870610.1128/JVI.79.14.8698-8706.200515994763 113.HebertD.N.FoellmerB.HeleniusA.Calnexin"/>
  <result pre="Protective Efficacy of Celgosivir in a Lethal Mouse Model for" exact="Dengue" post="Virus Infection Informs Dosing Regimen for a Proof of"/>
  <result pre="a Proof of Concept Clinical TrialAntivir. Res.201296323510.1016/j.antiviral.2012.07.00822867971 116.RathoreA.P.ParadkarP.N.WatanabeS.TanK.H.SungC.ConnollyJ.E.LowJ.OoiE.E.VasudevanS.G.Celgosivir Treatment Misfolds" exact="Dengue" post="Virus NS1 Protein, Induces Cellular pro-Survival Genes and Protects"/>
  <result pre="Mouse ModelAntivir. Res.20119245346010.1016/j.antiviral.2011.10.00222020302 117.PerryS.T.BuckM.D.PlummerE.M.PenmastaR.A.BatraH.StavaleE.J.WarfieldK.L.DwekR.A.ButtersT.D.AlonziD.S.et al.An Iminosugar with Potent Inhibition of" exact="Dengue" post="Virus Infection in VivoAntivir. Res.201398354310.1016/j.antiviral.2013.01.00423376501 118.ChangJ.SchulW.ButtersT.D.YipA.LiuB.GohA.LakshminarayanaS.B.AlonziD.ReinkensmeierG.PanX.et al.Combination of α-Glucosidase"/>
  <result pre="al.Combination of α-Glucosidase Inhibitor and Ribavirin for the Treatment of" exact="Dengue" post="Virus Infection in Vitro and in VivoAntivir. Res.201189263410.1016/j.antiviral.2010.11.00221073903 119.GoldbergM.F.SainiN.K.PorcelliS.A.Evasion"/>
  <result pre="to Win the WarCurr. Top. Microbiol. Immunol.200731616719217969448 123.TsaiY.T.ChangS.Y.LeeC.N.KaoC.L.Human TLR3 Recognizes" exact="Dengue" post="Virus and Modulates Viral Replication in VitroCell. Microbiol.20091160461510.1111/j.1462-5822.2008.01277.x19134117 124.ChattopadhyayS.SenG.C.dsRNA-activation"/>
  <result pre="effectsJ. Interferon Cytokine20143442743610.1089/jir.2014.003424905199 125.LiangZ.WuS.LiY.HeL.WuM.JiangL.FengL.ZhangP.HuangX.Activation of Toll-Like Receptor 3 Impairs the" exact="Dengue" post="Virus Serotype 2 Replication through Induction of IFN-β in"/>
  <result pre="Induction of IFN-β in Cultured Hepatoma CellsPLoS ONE20116e2334610.1371/journal.pone.002334621829730 126.SariolC.A.MartínezM.I.RiveraF.RodríguezI.V.PantojaP.AbelK.AranaT.GiavedoniL.HodaraV.WhiteL.J.et al.Decreased" exact="Dengue" post="Replication and an Increased Anti-Viral Humoral Response with the"/>
  <result pre="Anti-Viral Chemokine Production and IFN-Mediated Protection in Response to Antibody-Enhanced" exact="Dengue" post="Virus InfectionPLoS ONE20127e3405510.1371/journal.pone.003405522479521 130.NasirudeenA.M.A.WongH.H.ThienP.XuS.LamK.P.LiuD.X.RIG-I, MDA5 and TLR3 Synergistically Play"/>
  <result pre="and TLR3 Synergistically Play an Important Role in Restriction of" exact="Dengue" post="Virus InfectionPLoS Negl. Trop. Dis.20115e92610.1371/journal.pntd.000092621245912 131.KuraneI.InnisB.L.NimmannityaS.NisalakA.MeagerA.EnnisF.A.High Levels of Interferon"/>
  <result pre="Levels of Interferon Alpha in the Sera of Children with" exact="Dengue" post="Virus InfectionAm. J. Trop. Med. Hyg.19934822222910.4269/ajtmh.1993.48.2228447527 132.PerryS.T.BuckM.D.LadaS.M.SchindlerC.ShrestaS.STAT2 mediates innate"/>
  <result pre="InfectionAm. J. Trop. Med. Hyg.19934822222910.4269/ajtmh.1993.48.2228447527 132.PerryS.T.BuckM.D.LadaS.M.SchindlerC.ShrestaS.STAT2 mediates innate immunity to" exact="Dengue" post="virus in the absence of STAT1 via the type"/>
  <result pre="of primary dengue virus infection in miceJ. Immunol.20051753946395410.4049/jimmunol.175.6.394616148142 134.GomesA.L.V.WeeL.J.K.KhanA.M.GilL.H.V.G.MarquesE.T.A.Calzavara-SilvaC.E.TanT.W.Classification of" exact="Dengue" post="Fever Patients Based on Gene Expression Data Using Support"/>
  <result pre="Gene Expression Data Using Support Vector MachinesPLoS ONE20105e1126710.1371/journal.pone.001126720585645 135.RothmanA.L.Immunity to" exact="Dengue" post="Virus: A Tale of Original Antigenic Sin and Tropical"/>
  <result pre="to Cell Surface Heparan SulfateJ. Immunol.20061773185319210.4049/jimmunol.177.5.318516920957 139.BozzaF.A.CruzO.G.ZagneS.M.AzeredoE.L.NogueiraR.M.AssisE.F.BozzaP.T.KubelkaC.F.Multiplex Cytokine Profile from" exact="Dengue" post="Patients: MIP-1beta and IFN-Gamma as Predictive Factors for SeverityBMC"/>
  <result pre="Infect. Dis.200888610.1186/1471-2334-8-8618578883 140.BrasierA.R.ScottT.W.MorrisonA.C.KochelT.J.SprattH.M.BazanI.ForsheyB.M.GarciaJ.VictorS.S.RochaC.et al.A Three-Component Biomarker Panel for Prediction of" exact="Dengue" post="Hemorrhagic FeverAm. J. Trop. Med. Hyg.20128634134810.4269/ajtmh.2012.11-046922302872 141.TolfvenstamT.LindblomA.SchreiberM.J.LingL.ChowA.OoiE.E.HibberdM.L.Characterization of Early"/>
  <result pre="Med. Hyg.20128634134810.4269/ajtmh.2012.11-046922302872 141.TolfvenstamT.LindblomA.SchreiberM.J.LingL.ChowA.OoiE.E.HibberdM.L.Characterization of Early Host Responses in Adults with" exact="Dengue" post="DiseaseBMC Infect. Dis.20111120910.1186/1471-2334-11-20921810247 142.FagundesC.T.CostaV.V.CisalpinoD.AmaralF.A.SouzaP.R.S.SouzaR.S.RyffelB.VieiraL.Q.SilvaT.A.AtrasheuskayaA.et al.IFN-γ Production Depends on IL-12"/>
  <result pre="IL-12 and IL-18 Combined Action and Mediates Host Resistance to" exact="Dengue" post="Virus Infection in a Nitric Oxide-Dependent MannerPLoS Negl. Trop."/>
  <result pre="InfectionPLoS Negl. Trop. Dis.20126e166310.1371/journal.pntd.000166322666512 144.PacsaA.S.AgarwalR.ElbishbishiE.A.ChaturvediU.C.NagarR.MustafaA.S.Role of Interleukin-12 in Patients with" exact="Dengue" post="Hemorrhagic FeverFEMS Immunol. Med. Microbiol.20002815115510.1111/j.1574-695X.2000.tb01470.x10799806 145.Neves-SouzaP.C.AzeredoE.L.ZagneS.M.Valls-de-SouzaR.ReisS.R.CerqueiraD.I.NogueiraR.M.KubelkaC.F.Inducible nitric oxide synthase"/>
  <result pre="145.Neves-SouzaP.C.AzeredoE.L.ZagneS.M.Valls-de-SouzaR.ReisS.R.CerqueiraD.I.NogueiraR.M.KubelkaC.F.Inducible nitric oxide synthase (iNOS) expression in monocytes during acute" exact="Dengue" post="Fever in patients and during in vitro infectionBMC Infect."/>
  <result pre="infectionBMC Infect. Dis.200556410.1186/1471-2334-5-6416109165 146.CharnsilpaW.TakhampunyaR.EndyT.P.MammenM.P.LibratyD.H.UbolS.Nitric Oxide Radical Suppresses Replication of Wild-Type" exact="Dengue" post="2 Viruses in VitroJ. Med. Virol.200577899510.1002/jmv.2041816032750 147.GuntherV.J.PutnakR.EckelsK.H.MammenM.P.SchererJ.M.LyonsA.SunW.A human challenge"/>
  <result pre="Responses in Peripheral Blood Mononuclear Cells Obtained Prior to Secondary" exact="Dengue" post="Virus Infections in Thai SchoolchildrenJ. Infect. Dis.20021851697170310.1086/34082212085313 149.AtrasheuskayaA.PetzelbauerP.FredekingT.M.IgnatyevG.Anti-TNF Antibody"/>
  <result pre="SchoolchildrenJ. Infect. Dis.20021851697170310.1086/34082212085313 149.AtrasheuskayaA.PetzelbauerP.FredekingT.M.IgnatyevG.Anti-TNF Antibody Treatment Reduces Mortality in Experimental" exact="Dengue" post="Virus InfectionFEMS Immunol. Med. Microbiol.200335334210.1111/j.1574-695X.2003.tb00646.x12589955 150.ShrestaS.ShararK.L.PrigozhinD.M.BeattyP.R.HarrisE.Murine Model for Dengue"/>
  <result pre="Experimental Dengue Virus InfectionFEMS Immunol. Med. Microbiol.200335334210.1111/j.1574-695X.2003.tb00646.x12589955 150.ShrestaS.ShararK.L.PrigozhinD.M.BeattyP.R.HarrisE.Murine Model for" exact="Dengue" post="Virus-Induced Lethal Disease with Increased Vascular PermeabilityJ. Virol.200680102081021710.1128/JVI.00062-0617005698 151.ZellwegerR.M.PrestwoodT.R.ShrestaS.Supplemental"/>
  <result pre="Liver Sinusoidal Endothelial Cells in a Mouse Model of Severe" exact="Dengue" post="DiseaseCell Host Microbe2010712813910.1016/j.chom.2010.01.00420153282 152.Assunção-MirandaI.AmaralF.A.BozzaF.A.FagundesC.T.SousaL.P.SouzaD.G.PachecoP.Barbosa-LimaG.GomesR.N.BozzaP.T.et al.Contribution of Macrophage Migration Inhibitory"/>
  <result pre="al.Contribution of Macrophage Migration Inhibitory Factor to the Pathogenesis of" exact="Dengue" post="Virus InfectionFASEB J.20102421822810.1096/fj.09-13946919776337 153.KyleJ.L.HarrisE.Global Spread and Persistence of DengueAnnu."/>
  <result pre="Receptors CCR1, CCR2 and CCR4 in the Pathogenesis of Experimental" exact="Dengue" post="Infection in MicePLoS ONE.20105e1568010.1371/journal.pone.001568021206747 155.RennesonJ.GuabirabaR.MailletI.A detrimental role for invariant"/>
  <result pre="via hypothalamic AMP-activated protein kinaseJ. Biol. Chem.2004279199701997610.1074/jbc.M40216520015028725 158.MackenzieJ.M.KhromykhA.A.PartonR.G.Cholesterol Manipulation by" exact="West Nile" post="Virus Perturbs the Cellular Immune ResponseCell Host Microbe2007222923910.1016/j.chom.2007.09.00318005741 159.Martínez-GutierrezM.CastellanosJ.E.Gallego-GómezJ.C.Statins"/>
  <result pre="Virus Perturbs the Cellular Immune ResponseCell Host Microbe2007222923910.1016/j.chom.2007.09.00318005741 159.Martínez-GutierrezM.CastellanosJ.E.Gallego-GómezJ.C.Statins Reduce" exact="Dengue" post="Virus Production via Decreased Virion AssemblyIntervirology20115420221610.1159/00032189221293097 160.PohM.K.ShuiG.XieX.ShiP.Y.WenkM.R.GuF.U18666A, an Intra-Cellular"/>
  <result pre="Decreased Virion AssemblyIntervirology20115420221610.1159/00032189221293097 160.PohM.K.ShuiG.XieX.ShiP.Y.WenkM.R.GuF.U18666A, an Intra-Cellular Cholesterol Transport Inhibitor, Inhibits" exact="Dengue" post="Virus Entry and ReplicationAntivir. Res.20129319119810.1016/j.antiviral.2011.11.01422146564 161.Soto-AcostaR.Bautista-CarbajalP.SyedG.H.SiddiquiA.Del AngelR.M.Nordihydroguaiaretic Acid (NDGA)"/>
  <result pre="161.Soto-AcostaR.Bautista-CarbajalP.SyedG.H.SiddiquiA.Del AngelR.M.Nordihydroguaiaretic Acid (NDGA) Inhibits Replication and Viral Morphogenesis of" exact="Dengue" post="VirusAntivir. Res.201410913214010.1016/j.antiviral.2014.07.00225017471 162.HyrinaA.MengF.McArthurS.J.EivemarkS.NabiI.R.JeanF.Human Subtilisin Kexin Isozyme-1 (SKI-1)/Site-1 Protease (S1P)"/>
  <result pre="Virus AgentsPLoS ONE201712e017448310.1371/journal.pone.017448328339489 163.MazzuccoM.B.TalaricoL.B.VatanseverS.CarroA.C.FascioM.L.D’AccorsoN.B.GarcíaC.C.DamonteE.B.Antiviral Activity of an N-Allyl Acridone against" exact="Dengue" post="VirusJ. Biomed. Sci.2015222910.1186/s12929-015-0134-225908170 164.HoffmannH.-H.KunzA.SimonV.A.PaleseP.ShawM.L.Broad-Spectrum Antiviral That Interferes with de"/>
  <result pre="Novo Pyrimidine BiosynthesisProc. Natl. Acad. Sci. USA20111085777578210.1073/pnas.110114310821436031 165.DiamondM.S.ZachariahM.HarrisE.Mycophenolic Acid Inhibits" exact="Dengue" post="Virus Infection by Preventing Replication of Viral RNAVirology200230421122110.1006/viro.2002.168512504563 166.FurutaY.TakahashiK.ShirakiK.SakamotoK.SmeeD.F.BarnardD.L.GowenB.B.JulanderJ.G.MorreyJ.D.T-705"/>
  <result pre="of Sulfated Galactomannans against Yellow Fever Virus (BeH111 Strain) and" exact="Dengue" post="1 Virus (Hawaii Strain)Antivir. Res.20036020120810.1016/S0166-3542(03)00175-X14638396 168.TalaricoL.B.PujolC.A.ZibettiR.G.M.FaríaP.C.S.NosedaM.D.DuarteM.E.R.DamonteE.B.The Antiviral Activity of"/>
  <result pre="(Hawaii Strain)Antivir. Res.20036020120810.1016/S0166-3542(03)00175-X14638396 168.TalaricoL.B.PujolC.A.ZibettiR.G.M.FaríaP.C.S.NosedaM.D.DuarteM.E.R.DamonteE.B.The Antiviral Activity of Sulfated Polysaccharides against" exact="Dengue" post="Virus Is Dependent on Virus Serotype and Host CellAntivir."/>
  <result pre="Antiviral Activity of Carbohydrate-Binding Agents against the Four Serotypes of" exact="Dengue" post="Virus in Monocyte-Derived Dendritic CellsPLoS ONE20116e2165810.1371/journal.pone.002165821738755 170.LiangY.De WispelaereM.CarocciM.LiuQ.WangJ.YangP.L.GrayN.S.Structure-Activity Relationship"/>
  <result pre="Multivalent Inhibitor of the DC-SIGN Dependent Uptake of HIV-1 and" exact="Dengue" post="VirusBiomaterials2014354175418410.1016/j.biomaterials.2014.01.01424508075 172.KouretovaJ.HammamyM.Z.EppA.HardesK.KallisS.ZhangL.HilgenfeldR.BartenschlagerR.SteinmetzerT.Effects of NS2B-NS3 Protease and Furin Inhibition on"/>
  <result pre="Dengue VirusBiomaterials2014354175418410.1016/j.biomaterials.2014.01.01424508075 172.KouretovaJ.HammamyM.Z.EppA.HardesK.KallisS.ZhangL.HilgenfeldR.BartenschlagerR.SteinmetzerT.Effects of NS2B-NS3 Protease and Furin Inhibition on" exact="West Nile" post="and Dengue Virus ReplicationJ. Enzym. Inhib. Med. Chem.20173271272110.1080/14756366.2017.130652128385094 173.HotokezakaH.SakaiE.KanaokaK.SaitoK.MatsuoK.I.KitauraH.NakayamaK.U0126"/>
  <result pre="of NS2B-NS3 Protease and Furin Inhibition on West Nile and" exact="Dengue" post="Virus ReplicationJ. Enzym. Inhib. Med. Chem.20173271272110.1080/14756366.2017.130652128385094 173.HotokezakaH.SakaiE.KanaokaK.SaitoK.MatsuoK.I.KitauraH.NakayamaK.U0126 and PD98059,"/>
  <result pre="osteoclast-like cellsJ. Biol. Chem.2002277473664737210.1074/jbc.M20828420012237315 174.SreekanthG.P.ChuncharuneeA.SirimontapornA.PanaamponJ.NoisakranS.YenchitsomanusP.T.LimjindapornT.SB203580 Modulates P38 MAPK Signaling and" exact="Dengue" post="Virus-Induced Liver Injury by Reducing MAPKAPK2, HSP27, and ATF2"/>
  <result pre="178.PuS.Y.XiaoF.SchorS.BekermanE.ZaniniF.Barouch-BentovR.NagamineC.M.EinavS.Feasibility and Biological Rationale of Repurposing Sunitinib and Erlotinib for" exact="Dengue" post="TreatmentAntivir. Res.2018155677510.1016/j.antiviral.2018.05.00129753658 179.ChenH.H.ChenC.C.LinY.S.ChangP.C.LuZ.Y.LinC.F.ChenC.L.ChangC.P.AR-12 Suppresses Dengue Virus Replication by down-Regulation"/>
  <result pre="Repurposing Sunitinib and Erlotinib for Dengue TreatmentAntivir. Res.2018155677510.1016/j.antiviral.2018.05.00129753658 179.ChenH.H.ChenC.C.LinY.S.ChangP.C.LuZ.Y.LinC.F.ChenC.L.ChangC.P.AR-12 Suppresses" exact="Dengue" post="Virus Replication by down-Regulation of PI3K/AKT and GRP78Antivir. Res.201714215816828238876"/>
  <result pre="Res.2014111829210.1016/j.antiviral.2014.09.00425241249 181.ChangJ.SchulW.YipA.XuX.GuoJ.T.BlockT.M.Competitive Inhibitor of Cellular α-Glucosidases Protects Mice from Lethal" exact="Dengue" post="Virus InfectionAntivir. Res.20119236937110.1016/j.antiviral.2011.08.00321854808 182.GuB.MasonP.WangL.NortonP.BourneN.MoriartyR.MehtaA.DespandeM.ShahR.BlockT.Antiviral Profiles of Novel Iminocyclitol Compounds"/>
  <result pre="Profiles of Novel Iminocyclitol Compounds against Bovine Viral Diarrhea Virus," exact="West Nile" post="Virus, Dengue Virus and Hepatitis B VirusAntivir. Chem. Chemother.200718495910.1177/09563202070180010517354651"/>
  <result pre="Iminocyclitol Compounds against Bovine Viral Diarrhea Virus, West Nile Virus," exact="Dengue" post="Virus and Hepatitis B VirusAntivir. Chem. Chemother.200718495910.1177/09563202070180010517354651 183.LiangP.H.ChengW.C.LeeY.L.YuH.P.WuY.T.LinY.L.WongC.H.Novel Five-Membered"/>
  <result pre="of N -Alkylated Deoxynojirimycin (DNJ) Derivatives for the Treatment of" exact="Dengue" post="Virus InfectionJ. Med. Chem.2012556061607510.1021/jm300171v22712544 186.PlummerE.BuckM.D.SanchezM.GreenbaumJ.A.TurnerJ.GrewalR.KloseB.SampathA.WarfieldK.L.PetersB.et al.Dengue Virus Evolution under"/>
  <result pre="Heme Oxygenase 1 Is a Potential Host Cell Factor against" exact="Dengue" post="Virus ReplicationSci. Rep.201663217610.1038/srep3217627553177 188.YuJ.S.WuY.H.TsengC.K.LinC.K.HsuY.C.ChenY.H.LeeJ.C.Schisandrin A Inhibits Dengue Viral Replication"/>
  <result pre="Cell Factor against Dengue Virus ReplicationSci. Rep.201663217610.1038/srep3217627553177 188.YuJ.S.WuY.H.TsengC.K.LinC.K.HsuY.C.ChenY.H.LeeJ.C.Schisandrin A Inhibits" exact="Dengue" post="Viral Replication via Upregulating Antiviral Interferon Responses through STAT"/>
  <result pre="Antiviral Interferon Responses through STAT Signaling PathwaySci. Rep.201774517110.1038/srep4517128338050 189.YuJ.S.TsengC.K.LinC.K.HsuY.C.WuY.H.HsiehC.L.LeeJ.C.Celastrol Inhibits" exact="Dengue" post="Virus Replication via Up-Regulating Type I Interferon and Downstream"/>
  <result pre="Innate Immunity to Restrict the Replication of Hepatitis C and" exact="Dengue" post="VirusFront. Microbiol.2017866810.3389/fmicb.2017.0066828473813 193.ChiangC.BeljanskiV.YinK.Sequence-specific modifications enhance the broad-spectrum antiviral response"/>
  <result pre="broad-spectrum antiviral response activated by RIG-I agonistsJ. Virol.2015898011802510.1128/JVI.00845-1526018150 194.ShafeeN.AbuBakarS.Zinc Accelerates" exact="Dengue" post="Virus Type 2-Induced Apoptosis in Vero CellsFEBS Lett.2002524202410.1016/S0014-5793(02)02991-512135735 195.CorrêaG.LindenbergC.D.A.Fernandes-SantosC.GandiniM.PaivaF.P.Coutinho-SilvaR.KubelkaC.F.The"/>
  <result pre="CellsFEBS Lett.2002524202410.1016/S0014-5793(02)02991-512135735 195.CorrêaG.LindenbergC.D.A.Fernandes-SantosC.GandiniM.PaivaF.P.Coutinho-SilvaR.KubelkaC.F.The Purinergic Receptor P2X7 Role in Control of" exact="Dengue" post="Virus-2 Infection and Cytokine/Chemokine Production in Infected Human MonocytesImmunobiology201622179480210.1016/j.imbio.2016.02.00326969484"/>
  <result pre="and Cytokine/Chemokine Production in Infected Human MonocytesImmunobiology201622179480210.1016/j.imbio.2016.02.00326969484 196.MelloC.D.S.ValenteL.M.M.WolffT.Lima-JuniorR.S.FialhoL.G.MarinhoC.F.AzeredoE.L.Oliveira-PintoL.M.PereiraR.D.C.A.SianiA.C.et al.Decrease in" exact="Dengue" post="Virus-2 Infection and Reduction of Cytokine/Chemokine Production by Uncaria"/>
  <result pre="Antiviral Activities of Uncaria Tomentosa on Human Monocytes Infected with" exact="Dengue" post="Virus-2Int. Immunopharmacol.2008846847610.1016/j.intimp.2007.11.01018279801 198.WagstaffK.M.HarrichD.HeatonS.M.SivakumaranH.JansD.A.Ivermectin Is a Specific Inhibitor of Importin"/>
  <result pre="α/β-Mediated Nuclear Import Able to Inhibit Replication of HIV-1 and" exact="Dengue" post="VirusBiochem. J.201244385185610.1042/BJ2012015022417684 199.PanX.B.HanJ.C.CongX.WeiL.BST2/Tetherin Inhibits Dengue Virus Release from Human"/>
  <result pre="Inhibit Replication of HIV-1 and Dengue VirusBiochem. J.201244385185610.1042/BJ2012015022417684 199.PanX.B.HanJ.C.CongX.WeiL.BST2/Tetherin Inhibits" exact="Dengue" post="Virus Release from Human Hepatoma CellsPLoS ONE20127e5103310.1371/journal.pone.005103323236425 200.TrungD.T.WillsB.Systemic Vascular"/>
  <result pre="from Human Hepatoma CellsPLoS ONE20127e5103310.1371/journal.pone.005103323236425 200.TrungD.T.WillsB.Systemic Vascular Leakage Associated with" exact="Dengue" post="Infections—The Clinical PerspectiveSpringerBerlin/Heidelberg, Germany2010 201.GrögerM.PasteinerW.IgnatyevG.MattU.KnappS.AtrasheuskayaA.BukinE.FriedlP.ZinklD.Hofer-WarbinekR.et al.Peptide Bβ15-42 Preserves Endothelial"/>
  <result pre="Function in ShockPLoS ONE20094e539110.1371/annotation/9ae032a2-c48d-46d9-9f8f-d3f401714e4219401765 202.ChuangY.C.LeiH.Y.LiuH.S.LinY.S.FuT.F.YehT.M.Macrophage Migration Inhibitory Factor Induced by" exact="Dengue" post="Virus Infection Increases Vascular PermeabilityCytokine20115422223110.1016/j.cyto.2011.01.01321320786 203.KubelkaC.AzeredoE.GandiniM.PintoL.Metalloproteinases Are Produced during"/>
  <result pre="Dengue Virus Infection Increases Vascular PermeabilityCytokine20115422223110.1016/j.cyto.2011.01.01321320786 203.KubelkaC.AzeredoE.GandiniM.PintoL.Metalloproteinases Are Produced during" exact="Dengue" post="Fever and MMP9 Is Associated with SeverityThe British Infection"/>
  <result pre="in Endothelial CellsPLoS ONE20127e4193210.1371/journal.pone.004193222860034 205.CostaV.V.FagundesC.T.SouzaD.G.TeixeiraM.M.Inflammatory and Innate Immune Responses in" exact="Dengue" post="InfectionAm. J. Pathol.20131821950196110.1016/j.ajpath.2013.02.02723567637 206.SouzaD.FagundesC.Essential Role of Platelet-Activating Factor Receptor"/>
  <result pre="206.SouzaD.FagundesC.Essential Role of Platelet-Activating Factor Receptor in the Pathogenesis of" exact="Dengue" post="Virus InfectionProc. Natl. Acad. Sci. USA2009106141381414310.1073/pnas.090646710619666557 207.RahmanS.M.AtikullahM.IslamM.N.MohaimenulM.AhammadF.IslamM.S.SahaB.RahmanM.H.Anti-inflammatory, antinociceptive and"/>
  <result pre="repository hosts. Figure 2 Host metabolic pathways are necessary for" exact="DENV" post="replication: As an enveloped virus, DENV requires fatty acids"/>
  <result pre="pathways are necessary for DENV replication: As an enveloped virus," exact="DENV" post="requires fatty acids for replication and virion envelopment, resulting"/>
  <result pre="into the endoplasmic reticulum (ER) and subsequently assemble with the" exact="DENV" post="virus. Glucose uptake in DENV-infected cells may increase through"/>
  <result pre="(GLUT-1) and hexokinase II (HK-II), the first enzyme of glycolysis." exact="DENV" post="infection alters glucose metabolism allosterically by up-regulation of glycolytic"/>
  <result pre="lipid [60,61]. Experimentally limiting glucose and fatty acid synthesis during" exact="DENV" post="infection, along with limiting glutamine levels, can help prevent"/>
  <result pre="with limiting glutamine levels, can help prevent infections. Figure 3" exact="DENV" post="receptors in human cells: DENV recognizes various types of"/>
  <result pre="help prevent infections. Figure 3 DENV receptors in human cells:" exact="DENV" post="recognizes various types of receptors present in the host"/>
  <result pre="Heparan sulfate was identified as the first molecule responsible for" exact="DENV" post="entry into mammalian cells, while sulfated glycosaminoglycans—ubiquitous molecules on"/>
  <result pre="the cell surface—were found to play a role in mediating" exact="DENV" post="attachment. CLEC4L (C-type lectin domain family 4, member L),"/>
  <result pre="that have a high affinity towards high-mannose ligands involved in" exact="DENV" post="entry into target cells, where C-type lectin domain family"/>
  <result pre="which are part of the receptor complex, assist in the" exact="DENV" post="binding. Lipid receptors phosphatydil serine (PtdSer), T-cell immunoglobulin and"/>
  <result pre="Another receptor, SR-BI, is also responsible for lipoprotein-associated interaction with" exact="DENV" post="and allows the virus to enter the host [76]."/>
  <result pre="to enter the host [76]. microorganisms-07-00296-t001_Table 1Table 1 List of" exact="DENV" post="inhibitors isolated by targeting host process. LLC-MK2 = rhesus"/>
  <result pre="I, IMP dehydrogenase = Inosine-5′-monophosphate dehydrogenase. Host Process Inhibitor(s) Target" exact="DENV" post="Types Cell Line(s) Tested Refs. Glycolytic pathway 2-deoxy- d-glucose"/>
  <result pre="acid biosynthesis DENV-4 Huh-7 cell [161] Orlistat Fatty acid biosynthesis" exact="DENV" post="-4, -2 HepG2 and HEK293T/17 Cell [161] PF-429242 Fatty"/>
 </snippets>
</snippetsTree>
